Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 1
1967 1
1968 6
1969 5
1970 8
1972 7
1973 2
1974 3
1975 4
1976 2
1977 1
1980 4
1981 5
1982 4
1983 4
1984 11
1985 5
1986 11
1987 12
1988 13
1989 19
1990 29
1991 25
1992 14
1993 20
1994 16
1995 18
1996 24
1997 24
1998 24
1999 24
2000 37
2001 30
2002 42
2003 30
2004 53
2005 49
2006 36
2007 33
2008 45
2009 42
2010 55
2011 57
2012 45
2013 43
2014 51
2015 54
2016 60
2017 45
2018 63
2019 60
2020 66
2021 32
Text availability
Article attribute
Article type
Publication date

Search Results

1,250 results
Results by year
Filters applied: . Clear all
Page 1
Evidence-based clinical practice guideline for adult Still's disease.
Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T. Mimura T, et al. Among authors: iwamoto m. Mod Rheumatol. 2018 Sep;28(5):736-757. doi: 10.1080/14397595.2018.1465633. Epub 2018 May 9. Mod Rheumatol. 2018. PMID: 29651907 Review.
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K. Iwamoto M, et al. Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8487-8492. doi: 10.1073/pnas.1811064116. Epub 2019 Apr 5. Proc Natl Acad Sci U S A. 2019. PMID: 30952782 Free PMC article.
Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
McCrea JB, Macha S, Adedoyin A, Marshall W, Menzel K, Cho CR, Liu F, Zhao T, Levine V, Kraft WK, Yoon E, Panebianco D, Stoch SA, Iwamoto M. McCrea JB, et al. Among authors: iwamoto m. J Clin Pharmacol. 2019 Oct;59(10):1331-1339. doi: 10.1002/jcph.1423. Epub 2019 Apr 16. J Clin Pharmacol. 2019. PMID: 30990905 Clinical Trial.
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, Sando Y, Yagita H, Koreth J, Kim HT, Alyea EP, Armand P, Cutler CS, Ho VT, Antin JH, Soiffer RJ, Maeda Y, Tanimoto M, Ritz J, Matsuoka KI. Asano T, et al. Among authors: iwamoto m. Blood. 2017 Apr 13;129(15):2186-2197. doi: 10.1182/blood-2016-09-741629. Epub 2017 Feb 1. Blood. 2017. PMID: 28151427 Free PMC article.
Consequences of Undervaccination - Measles Outbreak, New York City, 2018-2019.
Zucker JR, Rosen JB, Iwamoto M, Arciuolo RJ, Langdon-Embry M, Vora NM, Rakeman JL, Isaac BM, Jean A, Asfaw M, Hawkins SC, Merrill TG, Kennelly MO, Maldin Morgenthau B, Daskalakis DC, Barbot O. Zucker JR, et al. Among authors: iwamoto m. N Engl J Med. 2020 Mar 12;382(11):1009-1017. doi: 10.1056/NEJMoa1912514. N Engl J Med. 2020. PMID: 32160662
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Marshall WL, McCrea JB, Macha S, Menzel K, Liu F, van Schanke A, de Haes JIU, Hussaini A, Jordan HR, Drexel M, Kantesaria BS, Tsai C, Cho CR, Hulskotte EGJ, Butterton JR, Iwamoto M. Marshall WL, et al. Among authors: iwamoto m. J Clin Pharmacol. 2018 Jul;58(7):897-904. doi: 10.1002/jcph.1094. Epub 2018 Mar 26. J Clin Pharmacol. 2018. PMID: 29578577 Clinical Trial.
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.
Iwamoto M, Saso W, Nishioka K, Ohashi H, Sugiyama R, Ryo A, Ohki M, Yun JH, Park SY, Ohshima T, Suzuki R, Aizaki H, Muramatsu M, Matano T, Iwami S, Sureau C, Wakita T, Watashi K. Iwamoto M, et al. J Biol Chem. 2020 Jan 17;295(3):800-807. doi: 10.1074/jbc.AC119.010366. Epub 2019 Dec 12. J Biol Chem. 2020. PMID: 31836663 Free PMC article.
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial.
Schürmann D, Rudd DJ, Zhang S, De Lepeleire I, Robberechts M, Friedman E, Keicher C, Hüser A, Hofmann J, Grobler JA, Stoch SA, Iwamoto M, Matthews RP. Schürmann D, et al. Among authors: iwamoto m. Lancet HIV. 2020 Mar;7(3):e164-e172. doi: 10.1016/S2352-3018(19)30372-8. Epub 2020 Jan 3. Lancet HIV. 2020. PMID: 31911147 Clinical Trial.
N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B Virus.
Murayama A, Yamada N, Osaki Y, Shiina M, Aly HH, Iwamoto M, Tsukuda S, Watashi K, Matsuda M, Suzuki R, Tanaka T, Moriishi K, Suzuki T, Nishitsuji H, Sugiyama M, Mizokami M, Shimotohno K, Wakita T, Muramatsu M, Liang TJ, Kato T. Murayama A, et al. Among authors: iwamoto m. Hepatology. 2021 Feb;73(2):520-532. doi: 10.1002/hep.31308. Epub 2020 Oct 31. Hepatology. 2021. PMID: 32446278
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial.
Atsumi T, Tanaka Y, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Eguchi K, Watanabe A, Origasa H, Yasuda S, Yamanishi Y, Kita Y, Matsubara T, Iwamoto M, Shoji T, Togo O, Okada T, van der Heijde D, Miyasaka N, Koike T. Atsumi T, et al. Among authors: iwamoto m. Ann Rheum Dis. 2017 Aug;76(8):1348-1356. doi: 10.1136/annrheumdis-2016-210246. Epub 2017 Feb 2. Ann Rheum Dis. 2017. PMID: 28153828 Free PMC article. Clinical Trial.
1,250 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page